Vizora日本語

PeptiDreamPeptiDream Inc.4587東証プライム医薬品FY ending Dec 2024, consolidated, IFRS

PeptiDream FY ending Dec 2024 results

About 67% of PeptiDream's sales come from Drug Discovery and Development Business, with Radiopharmaceuticals Business making up much of the rest.

Out of every ¥100 of sales, about ¥45 is left as operating profit.

Revenue changed +62.6% from the prior year.

What changed from last year

FY ending Dec 2023 → FY ending Dec 2024

Revenue
+62.6%¥28.7B → ¥46.7B
Net income attributable to owners
+394.6%¥3.04B → ¥15B
Operating cash flow
+92.0%¥12.4B → ¥23.8B

Where the money goes

FY ending Dec 2023 → FY ending Dec 2024

Where ¥100 of sales goes

For every ¥100 PeptiDream sells, how much goes where, and how much is kept.

FY ending Dec 2024
Cost of sales
¥26
SG&A
¥20
Other costs
¥9
Operating profit
¥45
Net profit kept
¥32

Annual margin trends

Gross margin73.9%
FY ending Dec 2020: 81.6%81.6%FY ending Dec 2021: 74.8%74.8%FY ending Dec 2024: 73.9%73.9%FY20FY21FY21FY22FY23FY24
Operating margin45.2%
FY ending Dec 2020: 59.9%59.9%FY ending Dec 2021: 47.2%47.2%FY ending Dec 2024: 45.2%45.2%FY20FY21FY21FY22FY23FY24
Net margin32.2%
FY ending Dec 2020: 38.1%38.1%FY ending Dec 2021: 27.3%27.3%FY ending Dec 2021: 38.5%38.5%FY ending Dec 2022: 28.1%28.1%FY ending Dec 2023: 10.6%10.6%FY ending Dec 2024: 32.2%32.2%FY20FY21FY21FY22FY23FY24

Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.

Which businesses earn the money

Revenue by business segment, and the profit each one keeps.

FY ending Dec 2024

Profit by segment

※ Segment figures include inter-segment sales and do not sum to the company total

Sources

Show source documents (4)

  • EDINET (FSA Japan)

    有価証券報告書－第20期(2025/01/01－2025/12/31)

    ID S100XRP42026-03-18Open

  • EDINET (FSA Japan)

    有価証券報告書－第19期(2024/01/01－2024/12/31)

    ID S100VITV2025-03-28Open

  • EDINET (FSA Japan)

    有価証券報告書－第16期(令和3年1月1日－令和3年12月31日)

    ID S100NQLE2022-03-25Open

  • EDINET (FSA Japan)

    有価証券報告書－第15期(令和2年1月1日－令和2年12月31日)

    ID S100L1B02021-03-26Open

Extracted from XBRL: 41 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Other periods

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.

Open MarkdownShare on XSave image